A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies
Friedman D, Goel S, Desai K, Verdier-Pinard D, Kaubisch A, Bulgaru A, Camacho F, Goldberg G, Mani S. A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies. Journal Of Clinical Oncology 2004, 22: 2113-2113. DOI: 10.1200/jco.2004.22.14_suppl.2113.Peer-Reviewed Original ResearchA phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies
Friedman D, Goel S, Desai K, Verdier-Pinard D, Kaubisch A, Bulgaru A, Camacho F, Goldberg G, Mani S. A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies. Journal Of Clinical Oncology 2004, 22: 2113-2113. DOI: 10.1200/jco.2004.22.90140.2113.Peer-Reviewed Original Research